Civica Rx Gets $55m Investment
Strikes Deal With Blue Cross Blue Shield Insurance Group
Civica Rx has won an investment of $55m through a deal with the Blue Cross Blue Shield Association of US health insurance firms to create a new subsidiary that will acquire and develop generic filings to be launched in the US from 2022.
